IP Library Granted Patent US 8,530,415
Granted Patent B2
US 8,530,415 · App. 12/509,171 · Granted Sep 10, 2013

Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions

Inventors: Gail K. Naughton (San Diego, CA); Frank Ziegler (Encinitas, CA); Mark Baumgartner (San Diego, CA); Kyle Nickey (Vista, CA)
Assignee: Histogen, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,530,415
App. No.
12/509,171
Granted
Sep 10, 2013
Kind
B2
Abstract

The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Claims (20)

1. A tissue regeneration patch comprising a composition made by culturing fibroblast cells under hypoxic conditions for at least 2 weeks on a microcarrier bead or three-dimensional surface in a suitable growth medium containing basic FGF (bFGF), under 1-5% oxygen thereby producing multipotent stem cells, wherein the multipotent stem cells produce and secrete a soluble composition, collecting the composition after said 2 weeks and preparing a tissue regeneration patch comprising the soluble composition.

2. A tissue regeneration patch comprising a composition made by culturing fibroblast cells under hypoxic conditions for at least 2 weeks on a microcarrier bead or three-dimensional surface in a suitable growth medium containing basic FGF (bFGF), under 1-5% oxygen thereby producing multipotent stem cells, wherein the multipotent stem cells produce and secrete into the medium and onto the bead, cell, culture or three-dimensional surfaces an insoluble composition, collecting the composition after said 2 weeks and preparing the tissue regeneration patch comprising the insoluble composition.

3. A tissue regeneration patch comprising a composition made by culturing fibroblast cells under hypoxic conditions for at least 2 weeks on a microcarrier bead or three-dimensional surface in a suitable growth medium containing basic FGF (bFGF), under 1-5% oxygen thereby producing multipotent stem cells, wherein the multipotent stem cells produce and secrete into the medium a soluble composition and onto the bead, cell, culture or three-dimensional surface an insoluble composition, collecting a composition after said 2 weeks and preparing the tissue regeneration patch comprising the soluble and insoluble composition.

4. A tissue regeneration patch of any of claim 1 , 2 , or 3 , wherein the composition comprises extracellular matrix proteins.

5. A method of repair and/or regeneration of cells comprising contacting cells to be repaired or regenerated with a composition made by culturing fibroblast cells under hypoxic conditions for at least 2 weeks on a microcarrier bead or three-dimensional surface in a suitable growth medium containing basic FGF (bFGF), under 1-5% oxygen thereby producing multipotent stem cells, wherein the multipotent stem cells produce and secrete a soluble composition, collecting the composition after said 2 weeks producing a soluble composition and administering the composition to the cells to be repaired or regenerated, wherein repair or regeneration is effected.

6. A method of repair and/or regeneration of cells comprising contacting cells to be repaired or regenerated with a composition made by culturing fibroblast cells under hypoxic conditions for at least 2 weeks on a microcarrier bead or three-dimensional surface in a suitable growth medium containing basic FGF (bFGF), under 1-5% oxygen thereby producing multipotent stem cells, wherein the multipotent stem cells produce and secrete into the medium and onto the bead, cell, culture or three-dimensional surfaces an insoluble composition, collecting the composition after said 2 weeks and administering the composition to the cells to be repaired or regenerated, wherein repair or regeneration is effected.

7. A method of repair and/or regeneration of cells comprising contacting cells to be repaired or regenerated with a composition made by culturing fibroblast cells under hypoxic conditions for at least 2 weeks on a microcarrier bead or three-dimensional surface in a suitable growth medium containing basic FGF (bFGF), under 1-5% oxygen thereby producing multipotent stem cells, wherein the multipotent stem cells produce and secrete into the medium a soluble composition and onto the bead, cell, culture or three-dimensional surface an insoluble composition, collecting a composition after said 2 weeks and administering the composition to the cells to be repaired or regenerated, wherein repair or regeneration is effected.

8. A method of repair and/or regeneration of cells comprising contacting cells to be repaired or regenerated with a composition made by culturing fibroblast cells under hypoxic conditions for at least 2 weeks on a microcarrier bead or three-dimensional surface in a suitable growth medium containing basic FGF (bFGF), under 1-5% oxygen thereby producing multipotent stem cells, wherein the multipotent stem cells produce and secrete into the medium and onto surfaces, a composition, collecting the composition after said 2 weeks and administering the composition to the cells to be repaired or regenerated, wherein repair or regeneration is effected.

9. The method of any of claim 5 , 6 , 7 , or 8 , wherein the cells to which the composition is administered are osteochondral cells.

10. The method of any of claim 5 , 6 , 7 or 8 , wherein the composition comprises extracellular matrix proteins.

11. The method of any of claim 5 , 6 , 7 or 8 , wherein the fibroblasts are neonatal fibroblasts.

12. The method of any of claim 5 , 6 , 7 or 8 , wherein the three-dimensional surface comprises mesh.

13. The method of any of claim 5 , 6 , 7 or 8 , wherein the growth medium comprises serum.

14. The method of any of claim 5 , 6 , 7 or 8 , wherein the growth medium is serum-free.

15. The method of any of claim 5 , 6 , 7 or 8 , wherein collagen species are upregulated as compared with media produced in oxygen conditions of about 15-20% oxygen.

16. The method of claim 15 , wherein the collagen is selected from type V alpha 1; IX alpha 1; IX alpha 2; VI alpha 2; VIII alpha 1; IV, alpha 5; VII alpha 1; XVIII alpha 1; or XII alpha 1.

17. The method of any of claim 5 , 6 , 7 or 8 , wherein Wnt species are upregulated as compared with media produced in oxygen conditions of about 15-20% oxygen.

18. The method of claim 17 , wherein the Wnt species are Wnt7a and Wnt11.

19. The method of any of claim 5 , 6 , 7 or 8 , wherein laminin species are upregulated as compared with media produced in oxygen conditions of about 15-20% oxygen.

20. The method of claim 19 , wherein the laminin species is laminin 8.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2024
From: HISTOGEN INC.
To: ALLERGAN SALES, LLC
Reel/Frame 067559/0977 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2012
From: NAUGHTON, GAIL K.; ZIEGLER, FRANK; BAUMGARTNER, MARK; NICKEY, KYLE
To: HISTOGEN, INC.
Reel/Frame 028368/0741 →
Continuity (6)
Continuation In Part 12501312 · Jul 10, 2009
Continuation In Part 12363488 · Jan 30, 2009
Provisional Application 61024854 · Jan 30, 2008
Provisional Application 61034361 · Mar 6, 2008
Provisional Application 61050940 · May 6, 2008
Related Publication 20100158975A1 · Jun 24, 2010